Navigation Links
Eppendorf Filtertips epT.I.P.S. 46 mm

ProductsEppendorf Filtertips epT.I.P.S. 46 mm
Company Sigma-Aldrich
Item Eppendorf Filtertips epT.I.P.S. 46 mm
Features Inquire
Description Hydrophobic PE filter without self-sealing additives, permits sample recovery after accidental over-pipetting. All filters are sterile (to USP, DAB, Ph.Eur. standards) and PCR clean (free from human DNA, DNase, RNase and PCR inhibitors)
Info Sigma-Aldrich
Customer Service: (800) 521-8956
Web site: http://www.sigmaaldrich.com/Area_of_Interest/The_Americas/United_States.html

Related medicine products :

1. Eppendorf Thermomixer
2. Eppendorf Thermomixer R
3. Eppendorf ThermoStat Plus, without block
4. Eppendorf Refrigerated Multipurpose Centrifuge Model 5804R
5. Eppendorf Refrigerated Multipurpose Centrifuge Model 5810R
6. Eppendorf Heat Sealing Film
7. Eppendorf heat sealing film
8. Eppendorf PCR film, self adhesive
9. Eppendorf Heat Sealing Foil
10. Eppendorf PCR foil, self adhesive
11. Eppendorf Sealing Mat 96
... Tuttnauer manual autoclaves set the standard for ...e is designed to compliment any healthcare and lab...satisfy all of your sterilization needs. Time test... Tuttnauer product. The Tuttnauer M Series is also...
Subjective refraction unit, computer controlled and programmable. Two versions: with and without prisms.
... The Isoseeds I-125 are brachytherapy sources whic...alized tumors, especially in the prostate. The see...therapeutic effect, i.e. after radioactive decay i...e use. They are supplied in a sterile form. Isosee...
Non-sterile oncoseed seeds consists of a welded titanium capsule containing.
Medicine Products:
(Date:12/3/2008)...ass., Dec. 3 The Belmont(R) Rapid ...bat Support Hospitals to treat wounded,soldiers, ...ed with helping to,save the life of an Omaha, NE ...e times during a traffic stop. One of the bullets,...rupturing a major artery. , "Injury to this...
(Date:12/3/2008)...n,t respond at first not helped by maintenance tre...3 (HealthDay News) -- Maintenance therapy using lo...vanced chronic hepatitis C who haven,t responded t...ests. , The study also showed a surprising heal... course of four years. , "This course of treatm...
(Date:12/3/2008)... Cellastim, an animal-free recombinan...tperform animal and human derived serum in CHO cel..., CO (PRWEB) December 3, 2008 -- Cellastim has pro...lbumin in CHO media and can improve both the growt...ss a variety of chemically defined media. , , ,Stu...
(Date:12/3/2008)....J., Dec. 3 The followi..., New Jersey Hospital Association: , , "Sta...ospitals will share funding from the state,s $44 m...me news for those facilities, but the more soberin...hospitals have been turned away. While a worthy ef...
Breaking Medicine News(10 mins):Health News:Belmont(R) Rapid Infuser Helps Save Officer's Life 2Health News:Hepatitis C Therapy Useless for Some 2Health News:InVitria's Cellastim Delivers Superior Results in CHO Cell Culture 2
...ed scientists to draw a little closer in understan...enes// that cause them to be more infectious to pe...52 key genetic changes distinguish avian influenza.... This conclusion follows the analysis of the gene...
..., egg exports have been restarted in India after d... its first egg shipment to Muscat.// Due to the b... the countries around the world had stopped import...was brought under control successfully by the seve...
...Anbumani Ramadoss announced on Saturday that four ... in the country and one of them would be located//...Nadu State AIDS Control Society, Ramadoss said tha...sfusion Medicine. Other routine activities would ...
... flu developed by a research institute in the cent...5 paise per dose, amounting to less than a// cent,...ecurity Animal Disease Laboratory (HSADL), it is t...flu in the country. HSADL, which has the techniq...
Other Medicine News:Health News:Understanding the Evolution of Viruses a little more Clearly 2Health News:‘Bird flu-free’ India resumes egg expor 2Health News:Bird Flu Vaccine Developed in India Could be Available for 35 Paise per Dose 2
(Date:12/3/2008)...c. 3 The Leukemia & Lymphoma S...beginning of a new clinical trial of ISF35, a canc...Diego (UCSD). , , LLS is collaborating o...evelopment and approval of a novel approach aimed ...nd/or 17p deleted chronic lymphocytic leukemia (CL...
(Date:12/3/2008)...ewswire-FirstCall/ -- Vical Incorporated,(Nasdaq:...tter of intent with EIP,Eczacibasi Ilac Pazarlama...,s,Allovectin-7(R) immunotherapeutic product cand...ern Cyprus. EIP has agreed to obtain the necessary...y Vical upfront and milestone payments,plus a spe...
(Date:12/2/2008)... 2 TorreyPines Therapeutics, Inc. ... from a 26 patient Phase II trial evaluating three... dry mouth, in patients with Sjogren,s syndrome. ... significant increase in salivary flow production ...mg, and 20 mg. These doses were safe and well tole...
(Date:12/1/2008)... Vanda Pharmaceuticals I...Lancet , one of the world,s leading medical journa...ian regulator, experimental compound tasimelteon (...is entitled "Melatonin agonist tasimelteon (VEC-16...two randomised controlled multicentre trials." Res...
Breaking Medicine Technology:The Leukemia & Lymphoma Society and Memgen Announce New Chronic Lymphocytic Leukemia Clinical Trial 2The Leukemia & Lymphoma Society and Memgen Announce New Chronic Lymphocytic Leukemia Clinical Trial 3Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 2Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 3Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 4Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 5TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 2TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 3TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 4TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 5Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 2Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 4COMEDY CENTRAL 28R 29 Announces Live On Air Charity Special Night Of Too Many Stars 3A An Overbooked Benefit For Autism Education Hosted by Jon Stewar 13886 1COMEDY CENTRAL 28R 29 Announces Live On Air Charity Special Night Of Too Many Stars 3A An Overbooked Benefit For Autism Education Hosted by Jon Stewar 13886 2COMEDY CENTRAL 28R 29 Announces Live On Air Charity Special Night Of Too Many Stars 3A An Overbooked Benefit For Autism Education Hosted by Jon Stewar 13886 3MHA Announces Initial Results of the Specialty Pharmacy Member Profile Initiative 13883 1MHA Announces Initial Results of the Specialty Pharmacy Member Profile Initiative 13883 2MHA Announces Initial Results of the Specialty Pharmacy Member Profile Initiative 13883 3febit Appoints Michelle Lyles Ph D Vice President Marketing and Sales 3825 1febit Appoints Michelle Lyles Ph D Vice President Marketing and Sales 3825 2Virginia Beach Man Loses 17 Pounds on Top of a Previous 100 Pound Loss and Wins Major 2450 000 Prize 13879 1Virginia Beach Man Loses 17 Pounds on Top of a Previous 100 Pound Loss and Wins Major 2450 000 Prize 13879 2Virginia Beach Man Loses 17 Pounds on Top of a Previous 100 Pound Loss and Wins Major 2450 000 Prize 13879 3
...-, EDMONTON, April 16, 2007 /PRNewswire-FirstCall/...ed PX-866 as its next clinical,development candida...itol-3-kinase (PI3 kinase)/ PTEN/AKT pathway, an,i...ted in many,types of human cancer, including gliob...end at the American Association of Cancer,Research...
... 2007 - Artes Medical, Inc.,(Nasdaq:ARTE), a medic...acturing and commercializing a new category of aes...y announced that the,final 5-year safety and effic...ed non-resorbable injectable dermal filler will,be... Society for,Aesthetic Plastic Surgery (ASAPS) on ...
Other Medicine Technology:Biomira Selects PX-866 as Clinical Development Candidate and,Presents Promising Preclinical Data at AACR 2Biomira Selects PX-866 as Clinical Development Candidate and,Presents Promising Preclinical Data at AACR 3ArteFill 5-Year Data to Be Presented at American Society for,Aesthetic Plastic Surgery Annual Meeting 2ArteFill 5-Year Data to Be Presented at American Society for,Aesthetic Plastic Surgery Annual Meeting 3ArteFill 5-Year Data to Be Presented at American Society for,Aesthetic Plastic Surgery Annual Meeting 4